Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effects of aromatase inhibition on sex steroids, pituitary hormones, markers of bone turnover, muscle strength and cognition on older men

Trial Profile

The effects of aromatase inhibition on sex steroids, pituitary hormones, markers of bone turnover, muscle strength and cognition on older men

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2018

At a glance

  • Drugs Anastrozole (Primary) ; Testosterone (Primary)
  • Indications Depression; Diabetes mellitus; Hypogonadism; Muscular atrophy; Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 07 Mar 2016 Primary endpoint has been met. (Prostate volume by transrectal ultrasound by in testosterone group), as per an article published in the Journal of Clinical Endocrinology and Metabolism.
    • 07 Mar 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top